EVE
Price sensitive
EVE Raises $0.9m to Advance Drug Reformulation Strategy
EVE Health Group Ltd
No summary is available for this announcement — open the PDF to read it in full.
Sign in for more about this company, including guidance changes and other insights.
Sign in